Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Understanding The Policy Debate Around The ACA

With the Affordable Care Act (ACA) under fire from the new administration, there are a number of hot button issues under debate from both sides of the aisle.  Rather than try to attempt to predict the outcomes of the legislative debate, we wanted to highlight key areas of uncertainty with respect to the ACA, some possible outcomes, and how these might affect the US healthcare system. 

Between the Medicaid expansion (12mm enrollees) and the ACA exchanges (~8.5mm enrollees), about 20-21mm people get coverage through ACA-related plans.  The incremental coverage from the ACA is less than the headline number as some individual market buyers had bought plans prior to the ACA and migrated to ACA exchanges when they were created.  More conservative Republicans want to repeal the ACA immediately with a replacement plan sometime down the road.  Centrist Republicans prefer that repeal and replace are passed at the same time.  As of this writing, the trend among legislators is moving towards simultaneous repeal and replace.

The administration’s approach to reforming healthcare reform is focused on the individual insurance market and Medicaid.  By and large, Medicare and employer sponsored insurance will remain unchanged, especially in comparison with what the ACA did to the insurance market. 

 Individual market reforms:

The ACA standardized the individual market by instituting the essential health benefit packages that plans needed to offer if they wanted to be on the exchanges.  Essential health benefits span across 10 categories: 1. Ambulatory patient services; 2. Emergency services; 3. Hospitalization; 4. Maternity and newborn care; 5. Mental health and substance abuse disorder services including behavioral health treatment; 6. Prescription drugs; 7. Rehabilitative and habilitative services and devices; 8. Laboratory services; 9. Preventive and wellness services and chronic disease management; and 10. Pediatric services, including oral and vision care.  The ACA also standardized plan offerings’ metal tiers (platinum, gold, silver, and bronze) for the actuarial value of a plan’s benefit design for all plans that wished to offer new products on the exchanges.  Under this scheme, bronze plans come with a 60% actuarial value, meaning that for a standard population, the plan will pay 60% of healthcare expenses, while enrollees pay the remaining 40% with some combination of deductibles, copays, and coinsurance, while silver plans have a 70%, gold an 80%, and platinum a 90% value. 

Other reforms included the guaranteed coverage issue, community ratings to prevent insurers from varying premiums within geographic areas according to personal factors, and the individual mandate whereby individuals have to pay a penalty fee if they can afford insurance but choose not to purchase.  As part of the community rating, the Congress mandated that ACA plans only have age bands of 3:1.  That means plans can only charge seniors 3x more than what they charge younger folks while most states have age bands of 5:1.  To help people buy insurance, the ACA provided subsidies for people and families falling below 400% of the federal poverty limit, scaling down as income increases. 

While ACA has certainly changed how many Americans view healthcare, with more Americans expecting guaranteed coverage as one example, the legislation has not been perfect.  Subsidies have been insufficient, particularly for those individuals/families whose income places them just above the 400% of federal poverty limit threshold.  For many in this category, the plans available to them came with premiums that were higher than plans they would have been able to purchase pre-ACA. 

The reform of the individual market has a few broad themes:

  • Replacing the ACA subsidies with tax credits that are based on age rather than means, namely, greater tax credits with increasing age.
  • Repealing the metal level actuarial value requirements for plans offered in the individual market.
  • Expanding health savings accounts to allow increased contribution by individuals and families. 
  • Expand the range of age bands from 3:1 to the 4:1 or 5:1. 
  • To offset for the lack of an individual mandate, the GOP is proposing continuous coverage incentives that would increase premiums for folks who haven’t been insured for a period of time. In the most recently unveiled version of the American Health Care Act, this would be a 30% penalty charged to individuals who obtain coverage in a given year who had not had coverage in the preceding years.

Medicaid reform:

The three goals of Medicaid reform are to slow the growth of Medicaid spending, give states more flexibility in how they administer/run the program, and try to roll back part or all of the ACA-mandated Medicaid expansion. 

  • Slowing the growth of Medicaid spending by changing federal funding to the states to either block grants or a per capita cap: Under current law, states are paid a federal medical assistance percentage (FMAP) by the federal government that matches the state’s expenditures on Medicaid spending.  The FMAP percentages vary by state and range from 50% (10 states) to 76% (Mississippi) and are based on the average per capita income for each state relative to the national average.  By law, the FMAP cannot be less than 50%.  Under a block grant program, the federal government would give the states a fixed amount of money every year in lieu of matching funds.  The block grants would be based off of existing Medicaid spending in the state.  In a per capita cap, the federal government would pay the states a fixed amount per enrollee.  The difference between block grants and per capita caps is if a state sees a surge in enrollment in Medicaid, a per capita program would grow with enrollment while block grants would not grow with the enrollment. State governors have expressed a desire for per capita caps over block grants.
  • Giving states more flexibility in administering the programs: Federal law mandates states cover certain services in Medicaid.  The new administration and Congress have spoken about allowing states to cover populations differently and pay for different services.  The increased flexibility to the states is a tradeoff for the change in the funding mechanism from FMAP to block grants/per capita caps. 
  • Roll back the Medicaid expansion: The more conservative parts of the new administration and Congress want to revert Medicaid eligibility to pre-ACA levels.  The Medicaid expansion has covered about 12-15mm people.

Given the complex interplay of the various components of the ACA, there is no quick and easy fix to what have emerged as stumbling points of the ACA, as well as fundamental points of opposition that stem simply from a change in the party residing in the White House.  As both investors and individuals who avail themselves of healthcare services in the US, we continue to closely watch this space.